Home/Filings/4/0000882796-25-000005
4//SEC Filing

Frank Steven 4

Accession 0000882796-25-000005

CIK 0000882796other

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 4:07 PM ET

Size

4.5 KB

Accession

0000882796-25-000005

Insider Transaction Report

Form 4
Period: 2025-08-29
Frank Steven
Director
Transactions
  • Award

    Common Stock

    2025-08-29$8.31/sh+1,353$11,24316,052 total
Footnotes (1)
  • [F1]Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $11,250.

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1
  • filerCIK 0001583886

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:07 PM ET
Size
4.5 KB